Bengaluru-based cell and gene therapy start-up Immuneel Therapeutics on Monday announced the launch of Qartemi -- the countr ...

Immuneel Therapeutics, the start-up, backed by Kiran Mazumdar-Shaw, was the first in India to conduct CAR T-cell therapy ...

AstraZeneca’s Calquence plus chemoimmunotherapy approved in US for patients with previously untreated mantle cell lymphoma: Cambridge, UK Monday, January 20, 2025, 09:00 Hrs [IS ...

Immuneel Therapeutics launches affordable CAR-T therapy Qartemi for B-cell Non-Hodgkin Lymphoma, aiming to revolutionize ...

The therapy can cost anywhere between $350,000 and $700,000 globally. While Immuneel has brought it down to about ₹51 lakh to ...

Shaw, has introduced Qartemi, India's second CAR-T cell therapy, to treat B-cell Non-Hodgkin Lymphoma. This therapy is priced ...

Def Leppard played their first concert of 2025 without guitarist Vivian Campbell, who was absent due to cancer treatment, in ...

Cancer is one of the world’s leading causes of death. It is the third leading cause of death in the Philippines in 2023, ...